Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/08/19 → 28/02/23 |
Funding
- Wellcome Trust (Rcl): £257,366.21
'ECAT-Plus' - Alex Teagle - Maximising T cell cytotoxicity and persistence for long term anti-cancer protection for use in adoptive cell therapy (ACT).
- Zamoyska, Rose (Principal Investigator)
- Gilbert, Nick (Co-investigator)
- Henderson, Neil (Co-investigator)
- Jackson, Andrew (Co-investigator)
- Walmsley, Sarah (Co-investigator)
- Whyte, Moira (Co-investigator)